Sky Century Investment (SKYI) Cash & Current Investments (2012 - 2026)

Sky Century Investment (SKYI) reported Cash & Current Investments of $3360.0 for Q1 2026, up 619.49% quarter-over-quarter from $467.0 in Q4 2025.

Sky Century Investment (SKYI) Cash & Current Investments (2012 - 2026) Analysis & Trends

Sky Century Investment (SKYI) has 5 years of Cash & Current Investments data on file, last reported at $3360.0 in Q1 2026.

Cash & Current Investments for Q1 2026 came in at $3360.0, changed N/A year-over-year; the trailing twelve-month figure through Feb 2026 was $3360.0 (changed N/A YoY), and the FY2025 annual result was $477.0, changed N/A from the prior year.
Cash & Current Investments grew to $3360.0 in Q1 2026 per SKYI's latest filing, from $467.0 in the prior quarter.
Over five years, Cash & Current Investments peaked at $11312.0 in Q2 2025 and troughed at $467.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash & Current Investments (Qtr)
1	Teva Pharmaceutical Industries	38.77 Bn	35.04 Bn	1.97 Bn	3.74 Bn
2	Zoetis	34.11 Bn	32.16 Bn	1.62 Bn	1.94 Bn
3	United Therapeutics	23.68 Bn	21.53 Bn	648.10 Mn	2.15 Bn
4	Aurora Cannabis	16.48 Bn	16.40 Bn	33.43 Mn	77.77 Mn
5	Neurocrine Biosciences	16.19 Bn	14.88 Bn	800.70 Mn	1.32 Bn
6	Elanco Animal Health	11.44 Bn	11.01 Bn	785.00 Mn	428.00 Mn
7	Alkermes	7.28 Bn	6.77 Bn	-116.06 Mn	511.86 Mn
8	Lantheus Holdings	6.48 Bn	5.98 Bn	230.92 Mn	498.58 Mn
9	Hims & Hers Health	6.35 Bn	5.60 Bn	396.79 Mn	750.88 Mn
10	Sky Century Investment	-	-	31,666.00	3,360.00

Download Data